中文 | English
Return
Total: 3286 , 1/329
Show Home Prev Next End page: GO
Author:(Xiu-li LI)

1.NO/NOS system in prostate cancer

Ailing LI ; Ruijuan XIU

Journal of International Oncology 2013;40(8):612-614

2.Progress of in vitro amplification of hematopoietic stem cells

Xiu LI ; Mingsheng HE

International Journal of Biomedical Engineering 2011;34(1):50-53,61

3.Clinical therapeutic effect of rehabilitative therapy on dysphagia after cerebral stroke

Xiu-hua HE ; Ling LI

Chinese Journal of cardiovascular Rehabilitation Medicine 2014;23(5):513-515

4. Inhibitory effect of combined transfection of antisense oligonucleotides of VEGF-C and COX-2 on the expression of VEGF-C in breast carcinoma cell line

Chang-Xiu LI

Tumor 2008;28(2):117-120

5. Expression of CDX-2, PTEN, E-cadherin and NM23 in gastric cancer and its clinical significance

Xiu-Li WANG

Academic Journal of Second Military Medical University 2010;31(4):404-407

6.Application of large aperture spiral CT in radiotherapy simulation positioning

Xuenan LI ; Xia XIU ; Gaofeng LI

China Medical Equipment 2013;(10):16-18

7.Influence of tumor volume change on intensity modulated radiotherapy for nasopharyngeal carcinoma analyzed by repeated CT simulation

Xuenan LI ; Xia XIU ; Gaofeng LI

Chinese Journal of Radiological Medicine and Protection 2013;33(5):516-518

8.Errors of two CT simulation positioning methods in intensity-modulated radiotherapy: a comparative study

Xuenan LI ; Xia XIU ; Gaofeng LI

Chinese Journal of Radiation Oncology 2013;22(5):387-390

9.The effect of recombinant human CTLA-4Ig fusion protein on T lymphocytes in active rheumatoid arthritis patients

Zhihui BAO ; Xiu LI ; Yang LI

Chinese Journal of Rheumatology 2012;16(6):383-387

10.Analysis and treatment of explicit and occult Descemet's membrane detachment after phacoemulsification

Li-Gang, LI ; De-Xiu, ZHANG

International Eye Science 2016;16(11):2127-2129

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 3286 , 1/329 Show Home Prev Next End page: GO